经会阴前列腺穿刺活检研究进展

冯天瑞; 严维刚

doi:10.13201/j.issn.1001-1420.2021.06.013

经会阴前列腺穿刺活检研究进展

冯天瑞,
严维刚^,

- 中国医学科学院北京协和医学院北京协和医院泌尿外科(北京, 100730)

详细信息

通讯作者: 严维刚,E-mail:ywgpumch@sina.com

中图分类号: R699

收稿日期: 2020-03-24

Advances in transperineal biopsy of the prostate

FENG Tianrui,
YAN Weigang^,

- Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Beijing, 100730, China

More Information

Corresponding author: YAN Weigang, E-mail: ywgpumch@sina.com

Received Date: 24 March 2020

摘要

摘要: 前列腺活检仍是目前前列腺癌诊断的金标准,而经直肠途径前列腺穿刺活检因其易操作、成本低等优点仍为当前主流。近年来随着越来越多的研究显示出经直肠途径活检有着易漏诊前列腺前尖部肿瘤的缺陷且其感染相关并发症发生率近年来显著升高,人们更多的开始关注经会阴途径前列腺活检。经会阴途径活检有着与经直肠途径相当的阳性率,并可以更好地检出前列腺前尖部肿瘤并评估临床风险。而自由手经会阴前列腺穿刺活检的方式则为克服传统经会阴途径穿刺的缺点提出了新的解决方案。此外,经会阴途径活检在MRI辅助靶向穿刺活检方面亦表现良好。其良好的准确性以及相对于经直肠途径极低的感染风险让越来越多的人开始相信在不远的将来其将成为前列腺穿刺活检的新主流。
- 前列腺癌 /
- 活组织检查 /
- 会阴
Abstract: Prostate biopsy remains the gold standard for the diagnosis of prostate cancer(PCa), and transrectal prostate biopsy still takes the predominant place because of its easy operation and low cost. In recent years, more and more studies have shown that transrectal biopsy has the defect of easily missing anterior apical tumors of the prostate and the incidence of infectious complications has dramatically increased over time. Therefore, more attention has been paid to the transperineal biopsy approach. The transperineal approach has a comparable detection rate with the transrectal approach, as well as it can better detect tumors at the anterior or apical prostate and assess the clinical risk category. The free-hand transperineal prostate biopsy provides a new solution to overcome the shortcomings of traditional transperineal prostate biopsy. Besides, the transperineal biopsy approach has performed well in MRI-assisted targeted biopsy. Its good accuracy and extremely low risk of infection compared to the transrectal approach have led more and more people to believe that it will become the new mainstream of prostate biopsy soon.
- prostate cancer /
- biopsy /
- perineum

HTML全文

参考文献(62)

[1]	Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[2]	顾秀瑛,郑荣寿,张思维,等.2000—2014年中国肿瘤登记地区前列腺癌发病趋势及年龄变化分析[J].中华预防医学杂志,2018,52(6):586-592.
[3]	郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2019,41(1):19-28.
[4]	Rouvière O,Schoots IG,Mottet N,et al.Multiparametric Magnetic Resonance Imaging Before Prostate Biopsy:A Chain is Only as Strong as its Weakest Link[J].Eur Urol,2019,75(6):889-890.
[5]	Kalapara AA,Nzenza T,Pan HY,et al.Detection and localisation of primary prostate cancer using(68) Ga-PSMA PET/CT compared with mpMRI and radical prostatectomy specimens[J].BJU Int,2019.
[6]	Chang DT,Challacombe B,Lawrentschuk N.Transperineal biopsy of the prostate--is this the future?[J].Nat Rev Urol,2013,10(12):690-702.
[7]	Xue J,Qin Z,Cai H,et al.Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer:a meta-analysis and trial sequential analysis[J].Oncotarget,2017,8(14):23322-23336.
[8]	Borghesi M,Ahmed H,Nam R,et al.Complications After Systematic,Random,and Image-guided Prostate Biopsy[J].Eur Urol,2017,71(3):353-365.
[9]	Hossack T,Patel M I,Huo A,et al.Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy[J].J Urol,2012,188(3):781-785.
[10]	Grummet J,Gorin MA,Popert R,et al."TREXIT 2020":why the time to abandon transrectal prostate biopsy starts now[J].Prostate Cancer Prostatic Dis,2020,23(1):62-65.
[11]	Chang DT,Challacombe B,Lawrentschuk N.Transperineal biopsy of the prostate--is this the future?[J].Nat Rev Urol,2013,10(12):690-702.
[12]	Chun FK,Epstein JI,Ficarra V,et al.Optimizing performance and interpretation of prostate biopsy:a critical analysis of the literature[J].Eur Urol,2010,58(6):851-864.
[13]	Kuru TH,Wadhwa K,Chang RT,et al.Definitions of terms,processes and a minimum dataset for transperineal prostate biopsies:a standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics[J].BJU Int,2013,112(5):568-577.
[14]	Dundee PE,Grummet JP,Murphy DG.Transperineal prostate biopsy:template-guided or freehand?[J].BJU Int,2015,115(5):681-683.
[15]	Popert R.Transperineal magnetic resonance imaging--ultrasound fusion targeted biopsies(MRI-US FTB)of the prostate:the future of prostate diagnostics[J].BJU Int,2013,112(5):537-538.
[16]	Mottet N,van den Bergh RCN,Briers E,et al.EAU Guidelines[Z].2019.
[17]	Xiang J,Yan H,Li J,et al.Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer:a systematic review and meta-analysis[J].World J Surg Oncol,2019,17(1):31.
[18]	麦智鹏,严维刚,李汉忠,等.前列腺穿刺方法及其癌灶空间分布研究进展[J].中华泌尿外科杂志,2015,36(8):635-637.
[19]	Mai Z,Zhou Z,Yan W,et al.The transverse and vertical distribution of prostate cancer in biopsy and radical prostatectomy specimens[J].BMC Cancer,2018,18(1):1205.
[20]	Lawrentschuk N,Haider MA,Daljeet N,et al.'Prostatic evasive anterior tumours':the role of magnetic resonance imaging[J].BJU Int,2010,105(9):1231-1236.
[21]	Bittner N,Merrick G,Taira A,et al.Location and Grade of Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy After Negative Transrectal Ultrasound-guided Biopsy[J].Am J Clin Oncol,2018,41(8):723-729.
[22]	Dai J,Zhang X,Zhao J,et al.The value of transperineal apical prostate biopsy in predicting urethral/apical margin status after radical prostatectomy[J].Medicine(Baltimore),2019,98(43):e17633.
[23]	Scott S,Samaratunga H,Chabert C,et al.Is transperineal prostate biopsy more accurate than transrectal biopsy in determining final Gleason score and clinical risk category?A comparative analysis[J].BJU Int,2015,116 Suppl 3:26-30.
[24]	Mai Z,Xiao Y,Yan W,et al.Comparison of lesions detected and undetected by template-guided transperineal saturation prostate biopsy[J].BJU Int,2018,121(3):415-420.
[25]	Crawford ED,Rove KO,Barqawi AB,et al.Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens[J].Prostate,2013,73(7):778-787.
[26]	Grummet J.How to Biopsy:Transperineal Versus Transrectal,Saturation Versus Targeted,What's the Evidence?[J].Urol Clin North Am,2017,44(4):525-534.
[27]	Bass EJ,Donaldson IA,Freeman A,et al.Magnetic resonance imaging targeted transperineal prostate biopsy:a local anaesthetic approach[J].Prostate Cancer Prostatic Dis,2017,20(3):311-317.
[28]	严维刚,周毅,周智恩,等.模板引导下经会阴前列腺穿刺活检10年经验总结[J].中华泌尿外科杂志,2015,36(1):39-43.
[29]	Dundee PE,Grummet JP,Murphy DG.Transperineal prostate biopsy:template-guided or freehand?[J].BJU Int,2015,115(5):681-683.
[30]	Ristau BT,Allaway M,Cendo D,et al.Free-hand transperineal prostate biopsy provides acceptable cancer detection and minimizes risk of infection:evolving experience with a 10-sector template[J].Urol Oncol,2018,36(12):528.e15-528.e20.
[31]	Stefanova V,Buckley R,Flax S,et al.Transperineal Prostate Biopsies Using Local Anesthesia:Experience with 1,287 Patients.Prostate Cancer Detection Rate,Complications and Patient Tolerability[J].J Urol,2019,201(6):1121-1126.
[32]	Wetterauer C,Shahin O,Federer-Gsponer JR,et al.Feasibility of freehand MRI/US cognitive fusion transperineal biopsy of the prostate in local anaesthesia as in-office procedure-experience with 400 patients[J].Prostate Cancer Prostatic Dis,2020,23(3):429-434.
[33]	Emiliozzi P,Longhi S,Scarpone P,et al.The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen[J].J Urol,2001,166(3):845-850.
[34]	Meyer AR,Joice GA,Schwen ZR,et al.Initial Experience Performing In-office Ultrasound-guided Transperineal Prostate Biopsy Under Local Anesthesia Using the PrecisionPoint Transperineal Access System[J].Urology,2018,115:8-13.
[35]	Kum F,Elhage O,Maliyil J,et al.Initial outcomes of local anaesthetic freehand transperineal prostate biopsies in the outpatient setting[J].BJU Int,2020,125(2):244-252.
[36]	林恒之,李沪生,何必鸣,等.经会阴自由手和经会阴模板引导前列腺穿刺活检对PSA<20 ng/ml患者前列腺癌检出率的比较研究[J].中华泌尿外科杂志,2019,40(8):596-600.
[37]	Weinreb JC,Barentsz JO,Choyke PL,et al.PI-RADS Prostate Imaging-Reporting and Data System:2015,Version 2[J].Eur Urol,2016,69(1):16-40.
[38]	Schoots IG,Roobol MJ,Nieboer D,et al.Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy:a systematic review and meta-analysis[J].Eur Urol,2015,68(3):438-450.
[39]	Schoots IG,Nieboer D,Giganti F,et al.Is magnetic resonance imaging-targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low-risk prostate cancer?A systematic review and meta-analysis[J].BJU Int,2018,122(6):946-958.
[40]	Wegelin O,van Melick H,Hooft L,et al.Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies:A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration.Is There a Preferred Technique?[J].Eur Urol,2017,71(4):517-531.
[41]	Hamid S,Donaldson IA,Hu Y,et al.The SmartTarget Biopsy Trial:A Prospective,Within-person Randomised,Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk Stratification[J].Eur Urol,2019,75(5):733-740.
[42]	Wegelin O,Exterkate L,van der Leest M,et al.The FUTURE Trial:A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies[J].Eur Urol,2019,75(4):582-590.
[43]	Schouten MG,van der Leest M,Pokorny M,et al.Why and Where do We Miss Significant Prostate Cancer with Multi-parametric Magnetic Resonance Imaging followed by Magnetic Resonance-guided and Transrectal Ultrasound-guided Biopsy in Biopsy-naive Men?[J].Eur Urol,2017,71(6):896-903.
[44]	Giannarini G,Crestani A,Rossanese M,et al.Multiparametric Magnetic Resonance Imaging Targeted Biopsy for Early Detection of Prostate Cancer:All That Glitters Is Not Gold![J].Eur Urol,2017,71(6):904-906.
[45]	Tu X,Liu Z,Chang T,et al.Transperineal Magnetic Resonance Imaging-Targeted Biopsy May Perform Better Than Transrectal Route in the Detection of Clinically Significant Prostate Cancer:Systematic Review and Meta-analysis[J].Clin Genitourin Cancer,2019,17(5):e860-e870.
[46]	Pepe P,Garufi A,Priolo GD,et al.Multiparametric MRI/TRUS Fusion Prostate Biopsy:Advantages of a Transperineal Approach[J].Anticancer Res,2017,37(6):3291-3294.
[47]	Pepe P,Garufi A,Priolo G,et al.Transperineal Versus Transrectal MRI/TRUS Fusion Targeted Biopsy:Detection Rate of Clinically Significant Prostate Cancer[J].Clin Genitourin Cancer,2017,15(1):e33-e36.
[48]	Ber Y,Segal N,Tamir S,et al.A noninferiority within-person study comparing the accuracy of transperineal to transrectal MRI-US fusion biopsy for prostate-cancer detection[J].Prostate Cancer Prostatic Dis,2020,23(3):449-456.
[49]	Knaapila J,Kallio H,Hakanen AJ,et al.Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies:a prospective,registered,multicentre study[J].BJU Int,2018,122(2):203-210.
[50]	Johansen T,Zahl PH,Baco E,et al.Antibiotic resistance,hospitalizations,and mortality related to prostate biopsy:first report from the Norwegian Patient Registry[J].World J Urol,2020,38(1):17-26.
[51]	Liss MA,Ehdaie B,Loeb S,et al.An Update of the American Urological Association White Paper on the Prevention and Treatment of the More Common Complications Related to Prostate Biopsy[J].J Urol,2017,198(2):329-334.
[52]	Nam RK,Saskin R,Lee Y,et al.Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy[J].J Urol,2013,189(1 Suppl):S12-17;discussion S17-18.
[53]	Grummet JP,Weerakoon M,Huang S,et al.Sepsis and 'superbugs':should we favour the transperineal over the transrectal approach for prostate biopsy?[J].BJU Int,2014,114(3):384-388.
[54]	Berry B,Parry MG,Sujenthiran A,et al.Comparison of complications after transrectal and transperineal prostate biopsy:a national population-based study[J].BJU Int,2020,126(1):97-103.
[55]	Patel U,Dasgupta P,Amoroso P,et al.Infection after transrectal ultrasonography-guided prostate biopsy:increased relative risks after recent international travel or antibiotic use[J].BJU Int,2012,109(12):1781-1785.
[56]	王飞,丁雪飞,徐嘉男,等.模板引导下经会阴的前列腺投影穿刺活检的并发症分析[J].中华医学杂志,2019,99(6):428-431.
[57]	Miah S,Eldred-Evans D,Simmons L,et al.Patient Reported Outcome Measures for Transperineal Template Prostate Mapping Biopsies in the PICTURE Study[J].J Urol,2018,200(6):1235-1240.
[58]	Loeb S,Vellekoop A,Ahmed H U,et al.Systematic review of complications of prostate biopsy[J].Eur Urol,2013,64(6):876-892.
[59]	Quinlan M R,Bolton D,Casey RG.The management of rectal bleeding following transrectal prostate biopsy:A review of the current literature[J].Can Urol Assoc J,2018,12(3):E146-E153.
[60]	Ando T,Watanabe K,Mizusawa T,et al.Late-onset rectal bleeding with hemorrhagic shock after transrectal prostate needle biopsy[J].Urol Case Rep,2018,21:41-43.
[61]	Culkin DJ,Exaire EJ,Green D,et al.Anticoagulation and antiplatelet therapy in urological practice:ICUD/AUA review paper[J].J Urol,2014,192(4):1026-1034.
[62]	Giannarini G,Mogorovich A,Valent F,et al.Continuing or discontinuing low-dose aspirin before transrectal prostate biopsy:results of a prospective randomized trial[J].Urology,2007,70(3):501-505.